activity
20242026
collaborators
Showing 2025Show all

9 papers · 1 filter

cs.CV2025

AI for Mycetoma Diagnosis in Histopathological Images: The MICCAI 2024 Challenge

Hyam Omar Ali, Sahar Alhesseen, Lamis Elkhair +19

Mycetoma is a neglected tropical disease caused by fungi or bacteria leading to severe tissue damage and disabilities. It affects poor and rural communities and presents medical ch…

cs.CV2025

The MICCAI Federated Tumor Segmentation (FeTS) Challenge 2024: Efficient and Robust Aggregation Methods for Federated Learning

Akis Linardos, Sarthak Pati, Ujjwal Baid +25

We present the design and results of the MICCAI Federated Tumor Segmentation (FeTS) Challenge 2024, which focuses on federated learning (FL) for glioma sub-region segmentation in m…

cs.CV2025

Classifying Histopathologic Glioblastoma Sub-regions with EfficientNet

Sanyukta Adap, Ujjwal Baid, Spyridon Bakas

Glioblastoma (GBM) is the most common aggressive, fast-growing brain tumor, with a grim prognosis. Despite clinical diagnostic advancements, there have not been any substantial imp…

cs.CV2025

Analysis of the 2024 BraTS Meningioma Radiotherapy Planning Automated Segmentation Challenge

Dominic LaBella, Valeriia Abramova, Mehdi Astaraki +102

The 2024 Brain Tumor Segmentation Meningioma Radiotherapy (BraTS-MEN-RT) challenge aimed to advance automated segmentation algorithms using the largest known multi-institutional da…

cs.CV2025

BrainLesion Suite: A Flexible and User-Friendly Framework for Modular Brain Lesion Image Analysis

Florian Kofler, Marcel Rosier, Mehdi Astaraki +26

BrainLesion Suite is a versatile toolkit for building modular brain lesion image analysis pipelines in Python. Following Pythonic principles, BrainLesion Suite is designed to provi…

eess.IV2025

BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023

Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu +77

Pediatric central nervous system tumors are the leading cause of cancer-related deaths in children. The five-year survival rate for high-grade glioma in children is less than 20%.…